Role of [18F]-dopa–PET imaging in assessing movement disorders
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 43 (1) , 93-106
- https://doi.org/10.1016/j.rcl.2004.08.002
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography studyAnnals of Neurology, 1997
- Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomographyAnnals of Neurology, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Subdivisional involvement of nigrostriatal loop in idiopathic parkinson's disease and striatonigral degenerationAnnals of Neurology, 1989
- Nigrostriatal function in humans studied with positron emission tomographyAnnals of Neurology, 1989
- Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degenerationAnnals of Neurology, 1989
- Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsyAnnals of Neurology, 1989
- Synthesis and purification of l-6-[18F]fluorodopaInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985